EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment

Zhao Ge, MaoZe Zhang, Xujin Ning, Yijia Du, Lishuo Su, Xudong Wu, Jingyi Zhang, Tongzuo Liu, Xianliang Wang

MedComm · 2026-08 · 7 (8)

DOI: 10.1002/mco2.70875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 22.07.2026. Verfasst von Zhao Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China. Die Arbeit nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary microvascular dysfunction (CMD) is a key contributor to myocardial ischemia and cardiovascular diseases. It is characterized by abnormalities of the coronary microvasculature, leading to impaired myocardial perfusion. Although CMD has a high prevalence in patients with nonobstructive coronary artery disease and is associated with adverse cardiovascular events, its pathogenesis has not yet been fully elucidated. Current diagnostic approaches combine noninvasive and invasive methods, but there remains a lack of effective targeted therapies. This review discusses the epidemiology, pathophysiology, diagnostic strategies, and treatment options for CMD, with a particular focus on the protective role of the neuregulin‐1 (NRG‐1)/v‐erb‐b2 erythroblastic leukemia viral oncogene homolog B (ErbB) signaling pathway. We initially outline how the NRG‐1/ErbB pathway affects endothelial function, ventricular remodeling, oxidative stress, and myocardial angiogenesis, highlighting its potential as a therapeutic target. In addition, we explore emerging evidence that traditional Chinese medicine (TCM) interventions may regulate the NRG‐1/ErbB axis to improve microvascular function and cardiac outcomes. Overall, this review deepens our understanding of the mechanisms underlying CMD and provides new avenues for integrated precision therapies, including TCM, with the aim of improving clinical management and prognosis in patients with CMD.

Schlagwörter

Stichwörter der Autor:innen

NRG‐1/ErbB signaling pathwaycoronary microvascular dysfunctiondiagnosistraditional Chinese medicinetreatment

Autor:innen und Institutionen

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China.
  • National Clinical Research Center for Chinese Medicine Tianjin China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, Z., Zhang, M., Ning, X., Du, Y., Su, L., Wu, X., Zhang, J., Liu, T., & Wang, X. (2026). Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment. MedComm, 7(8). https://doi.org/10.1002/mco2.70875

Vancouver

Ge Z, Zhang M, Ning X, Du Y, Su L, Wu X, et al. Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment. MedComm. 2026;7(8). doi:10.1002/mco2.70875

BibTeX
@article{Ge2026,
  author = {Ge, Zhao and Zhang, MaoZe and Ning, Xujin and Du, Yijia and Su, Lishuo and Wu, Xudong and Zhang, Jingyi and Liu, Tongzuo and Wang, Xianliang},
  title = {Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {8},
  doi = {10.1002/mco2.70875}
}
Kostenlos starten →